clinical trial · NCT06493604
A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease
Dry Eye DiseaseReproxalap Ophthalmic Solution (0.25%)Vehicle Ophthalmic Solution
brief summary
A Randomized, Double-Masked, Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects with Dry Eye Disease
started
Jun 24, 2024
primary completion
Feb 27, 2025
completion
Feb 27, 2025
last updated
Dec 22, 2025
detailed description
Dry eye chamber challenge trial
official title
A Randomized, Double-Masked, Vehicle-Controlled Parallel Group Clinical Trial to Assess Efficacy and Safety of 0.25% Reproxalap Ophthalmic Solution Compared to Vehicle in Subjects With Dry Eye Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol